• Bluemtec’s October 30, 2026, correction names KDBI Healthcare Value-Up as buyer in place of KDB Investment following assignment of contractual rights.
• The new buyer will acquire 7,131,777 shares, representing a 21.07% stake, to become the largest shareholder.
• Transaction terms remain unchanged at KRW 23.07 billion, or KRW 3,235 per share.
• Closing is scheduled for November 27, 2026, subject to conditions, with full payment due at completion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluemtec Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030901313), on October 30, 2026, and is solely responsible for the information contained therein.